XML 80 R21.htm IDEA: XBRL DOCUMENT v2.4.0.6
Stock-Based Compensation
12 Months Ended
Dec. 31, 2012
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]  
Stock-Based Compensation
Stock-Based Compensation

Our stock-based compensation plans include the 2005 Equity Incentive Plan (the “2005 Plan”) and the 1987 Employee Stock Purchase Plan (“ESPP”).

2005 EQUITY INCENTIVE PLAN  |  Our equity incentive program is a broad-based, long-term retention program intended to attract, motivate, and retain talented employees as well as align stockholder and employee interests. The 2005 Plan provides stock-based incentive compensation (“awards”) to both our eligible employees and non-employee directors. Awards that may be granted under the 2005 Plan include non-qualified and incentive stock options, restricted stock units (“RSU”s), performance-based restricted stock units (“PRSU”s), restricted stock awards, stock appreciation rights, and stock bonus awards. To date, awards granted under the 2005 Plan consist of stock options, RSUs and PRSUs. The majority of stock-based awards granted under the 2005 Plan vest over four years. Stock options granted under the 2005 Plan have a maximum contractual term of ten years. As of December 31, 2012, the 2005 Plan had a total of 28.1 million shares reserved for future issuance, of which 21.2 million shares were available for future grants.

Historically, we used equity awards in the form of stock options as one of the means for recruiting and retaining highly skilled talent. RSUs and PRSUs are the most frequently issued type of long-term equity-based award for eligible employees.

A summary of activity for our RSUs and PRSUs for 2012 and information regarding RSUs and PRSUs outstanding and expected to vest as of December 31, 2012 is as follows:
(In thousands, except per share amounts and terms)
 
Number of
Shares
 
Weighted-Average
Grant-Date Fair Market Value
Per Share
 
Weighted-Average
Remaining Contractual
Term (in Years)
 
Aggregate
Intrinsic
Value(1)
Outstanding, December 31, 2011
 
8,176

 
$
31.62

 
 
 
 
Grants
 
2,412

 
$
33.58

 
 
 
 
Vested
 
(2,983
)
 
$
27.50

 
 
 
 
Forfeited
 
(645
)
 
$
32.02

 
 
 
 
Outstanding, December 31, 2012
 
6,960

 
$
34.03

 
1.5
 
$
239,354

Vested and expected to vest, December 31, 2012
 
6,166

 
$
34.03

 
1.4
 
$
212,051

(1)
Aggregate intrinsic value represents the closing price per share of our stock on December 31, 2012, multiplied by the number of RSUs and PRSUs outstanding or vested and expected to vest as of December 31, 2012.

The total fair value of RSUs and PRSUs vested and expensed during 2012, 2011 and 2010 was $81.0 million, $71.8 million and $53.4 million, respectively.

A summary of stock option activity for 2012 and information regarding stock options outstanding, exercisable, and vested and expected to vest as of December 31, 2012 is as follows:
(In thousands, except per share amounts and terms)
 
Number of
Shares
 
Weighted-Average
Exercise Price
Per Share
 
Weighted-Average
Remaining Contractual
Term (in Years)
 
Aggregate
Intrinsic
Value(1)
Outstanding, December 31, 2011
 
6,138

 
$
22.96

 
 
 
 
Grants
 
748

 
$
34.23

 
 
 
 
Exercises
 
(1,657
)
 
$
18.83

 
 
 
 
Forfeited/Cancelled/Expired
 
(66
)
 
$
31.16

 
 
 
 
Outstanding, December 31, 2012
 
5,163

 
$
25.81

 
4.1
 
$
50,937

Exercisable, December 31, 2012
 
3,791

 
$
21.80

 
2.4
 
$
49,262

Vested and expected to vest, December 31, 2012
 
4,992

 
$
25.44

 
3.9
 
$
50,788

(1)
For those stock options with an exercise price below the closing price per share on December 31, 2012, aggregate intrinsic value represents the difference between the exercise price and the closing price per share of our common stock on December 31, 2012, multiplied by the number of stock options outstanding, exercisable, or vested and expected to vest as of December 31, 2012.

For 2012, 2011 and 2010, 1.7 million, 4.8 million and 20.0 million non-qualified stock option shares were exercised, respectively. The total intrinsic value of stock options exercised for 2012, 2011 and 2010 was $30.6 million, $97.7 million and $139.6 million, respectively. The aggregate intrinsic value represents the difference between the exercise price and the selling price received by option holders upon the exercise of stock options during the period. The total cash received from employees as a result of employee stock option exercises during 2012, 2011 and 2010 was $31.2 million, $102.3 million and $437.4 million, respectively.

The total fair value of options vested and expensed during 2012, 2011 and 2010 was $4.9 million, $4.7 million and $3.6 million, respectively.  

1987 EMPLOYEE STOCK PURCHASE PLAN  |  Our ESPP has two consecutive, overlapping twelve-month offering periods, with a new period commencing on the first trading day on or after May 1 and November 1 of each year and terminating on the last trading day on or before April 30 and October 31. Each twelve-month offering period generally includes two six-month purchase periods. The purchase price at which shares are sold under the ESPP is 85% of the lower of the fair market value of a share of our common stock on (1) the first day of the offering period, or (2) the last trading day of the purchase period. If the fair market value at the end of any purchase period is less than the fair market value at the beginning of the offering period, each participant is automatically withdrawn from the current offering period following the purchase of shares on the purchase date and is automatically re-enrolled in the immediately following offering period.

As of December 31, 2012, 2.9 million shares were available for future issuance under the ESPP. Sales under the ESPP were 0.7 million shares of common stock at an average price of $27.90 per share for 2012, 0.7 million shares of common stock at an average price of $26.12 per share for 2011 and 1.0 million shares of common stock at an average price of $16.89 per share for 2010.


VALUATION AND EXPENSE INFORMATION |  The assumptions used to estimate the fair value of stock options, ESPP shares, RSUs and PRSUs were as follows:  
 
 
2012
 
2011
 
2010
Stock options:
 

 

 

Expected term (in years)
 
6.0

 
5.0

 
3.8

Expected stock price volatility
 
35.1
%
 
32.7
%
 
31.9
%
Risk-free interest rate
 
1.1
%
 
0.3
%
 
1.6
%
Dividend yield
 
0.8
%
 
0.6
%
 
0.8
%
Weighted-average estimated fair value
 
$
10.85

 
$
12.92

 
$
21.96

 
 

 

 

ESPP shares:
 

 

 

Expected term (in years)
 
1.0

 
0.8

 
0.7

Expected stock price volatility
 
36.8
%
 
35.9
%
 
31.4
%
Risk-free interest rate
 
0.2
%
 
0.1
%
 
0.3
%
Dividend yield
 
1.1
%
 
0.7
%
 
0.8
%
Weighted-average estimated fair value
 
$
9.61

 
$
12.03

 
$
6.68

 
 

 

 

RSUs and PRSUs:
 

 

 

Risk-free interest rate
 
0.3
%
 
0.6
%
 
0.8
%
Dividend yield
 
1.0
%
 
0.7
%
 
0.8
%
Weighted-average estimated fair value
 
$
32.90

 
$
41.30

 
$
26.87



For stock options, our expected term represents the weighted average period from the date of grant to exercise, cancellation, or expiration. For ESPP shares, the expected term represents the average term from the first day of the offering period to the purchase date.

Our expected stock price volatility assumption for stock options is estimated using a combination of implied volatility for publicly traded options on our stock with a term of one year or more and our historical stock price volatility. Our expected stock price volatility assumption for ESPP shares is estimated using a combination of implied volatility for publicly traded options on our stock with a term of six months and our historical stock price volatility.

The interest rate used to value stock options and ESPP shares approximates the risk-free interest rate of a zero-coupon Treasury bond on the date of grant with a maturity date that approximates the expected term of the award.

In addition, we apply an expected forfeiture rate when amortizing stock-based compensation expense. Our stock-based compensation expense included in the consolidated statements of comprehensive income was as follows:
(In thousands)
 
2012
 
2011
 
2010
 
 

 

 

Cost of sales
 
$
1,872

 
$
1,655

 
$
1,241

Research and development expense
 
41,652

 
36,410

 
27,298

Selling, general, and administrative expense
 
50,062

 
44,685

 
33,579

Pre-tax stock-based compensation expense
 
93,586

 
82,750

 
62,118

Income tax benefit
 
(23,998
)
 
(20,278
)
 
(18,298
)
Net stock-based compensation expense
 
$
69,588

 
$
62,472

 
$
43,820



No stock-based compensation was capitalized during any period presented above. As of December 31, 2012, unrecognized stock-based compensation cost related to outstanding unvested stock options, RSUs, PRSUs and ESPP shares that are expected to vest was approximately $170.9 million. This unrecognized stock-based compensation cost is expected to be recognized over a weighted average period of approximately 2.4 years. To the extent the actual forfeiture rate is different from our estimate, stock-based compensation related to these awards will be different from our expectations.

We settle employee stock option exercises, ESPP purchases, RSUs and PRSUs vesting with newly issued common shares.